Kalaris Therapeutics (KLRS) EPS (Basic) (2019 - 2026)
Kalaris Therapeutics (KLRS) posted quarterly EPS (Basic) of -$0.7 for Q1 2026, up 94.87% year-over-year from -$0.36 in Q1 2025, and up 1.57% quarter-over-quarter from -$0.71 in Q4 2025.
Kalaris Therapeutics (KLRS) EPS (Basic) (2019 - 2026) Analysis & Trends
Kalaris Therapeutics' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.7 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 94.87% year-over-year to -$0.7; the TTM figure through Mar 2026 stood at -$2.54 (up 90.35% YoY), while the FY2025 annual figure was -$3.65, up 70.4% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.7, up from -$0.71 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.55 in Q1 2024, with the low at -$45.4 in Q4 2023.
- The 5-year median for EPS (Basic) is -$7.71 (2024), against an average of -$8.71.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) tumbled 5156.03% in 2023, then jumped 96.29% in 2024.
- Kalaris Therapeutics' EPS (Basic) stood at -$0.86 in 2022, then sank by 5156.03% to -$45.4 in 2023, then jumped by 96.29% to -$1.69 in 2024, then jumped by 58.03% to -$0.71 in 2025, then gained by 1.57% to -$0.7 in 2026.
- Business Quant data shows KLRS's EPS (Basic) at -$0.7 in Q1 2026, -$0.71 in Q4 2025, and -$1.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Kalaris Therapeutics | 95.90 Mn | 95.90 Mn | - | -0.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.63 |
| Mar 31, 2026 | -0.70 |
| Dec 31, 2025 | -0.71 |
| Sep 30, 2025 | -1.00 |
| Jun 30, 2025 | -0.77 |
| Mar 31, 2025 | -13.57 |
| Dec 31, 2024 | -1.69 |
| Sep 30, 2024 | -7.71 |
| Jun 30, 2024 | -0.94 |
| Mar 31, 2024 | -0.55 |
| Dec 31, 2023 | -45.40 |
| Sep 30, 2023 | -8.94 |
| Jun 30, 2023 | -11.00 |
| Mar 31, 2023 | -11.13 |
| Dec 31, 2022 | -0.86 |
| Sep 30, 2022 | -11.39 |
| Jun 30, 2022 | -15.94 |
| Mar 31, 2022 | -15.76 |
| Dec 31, 2021 | 59.37 |
| Sep 30, 2021 | -16.62 |